Clin2
NCT06921395Possibly a fitRecruiting

Comparing two fertility drugs for IVF in women under 40

Female Infertility

Part of Women’s health & pregnancy clinical trials.

This trial tests how well and safely a new drug (Fang Le Shu) works compared to a standard drug (Guo Na Fen) for stimulating the ovaries to produce eggs for IVF. It may help women who have had trouble getting pregnant for at least a year.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
248 people
Ages
20 years to 39 years
Study type
Interventional

Who can take part

  • You are a woman between the ages of 20 and 39.
  • You have regular monthly periods (every 25 to 35 days).
  • Your basic hormone levels (FSH, LH, E2, P4) are normal.
  • You have had trouble getting pregnant for at least one year (or have a clear diagnosis of infertility).
  • Your body mass index (BMI) is 30 or below.
  • You have not had more than 3 failed IVF cycles in the past.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07772375Not yet recruiting
Comparing two starting hormone doses for IVF in healthy younger women

This trial compares two starting doses of follicle-stimulating hormone (FSH) during in vitro fertilization (IVF) to see which works better. FSH helps your ovaries produce eggs, and the study aims to find the best dose for women with good fertility prospects.

Ho Chi Minh City, Ho Chi Minh City
NCT07346235Not yet recruiting· Phase 3
Comparing two FSH doses for IVF patients with normal ovarian reserve

This trial tests whether a lower or higher dose of follicle-stimulating hormone (FSH) works better for women with normal egg supply. If you are starting your first or second IVF cycle, you may be able to join.

Pristina
NCT07340827Recruiting· Phase 3
Comparing two fertility drugs in Japanese women with hormone deficiency

This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.

Akita, Akita
NCT07553728Not yet recruiting
Fertility Treatment Safety Study in Women Ages 36–40

This trial tests a fertility injection called Corifollitropin alfa to help women aged 36–40 produce eggs for in-vitro fertilization (IVF). Researchers want to confirm it is safe and effective in this age group using a specific ovarian stimulation protocol.

Beijing, Beijing Municipality
NCT06995261Recruiting
Follitropin delta in a long hormone-suppression IVF cycle

This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.

Düsseldorf, North Rhine-Westphalia
NCT07794683Not yet recruiting· Phase 1
Comparing two versions of a fertility drug in healthy women

This study tests if a new version of a fertility drug (KM04) works like the standard version (Gonal-f) by giving healthy women either one and checking safety and how the body handles it. Participation lasts several weeks and involves taking birth control pills and daily injections.

Hear when a new Female Infertility trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.